Phlebotomy Training Services Enter into Partnership with the University of Bradford

Phlebotomy Training Services are extremely proud to announce that we have entered into a new partnership with the University of Bradford. This revolutionary partnership will see us providing phlebotomy training courses to the students of the University, as well as members of the public.

This comes as part of a new scheme launched by the University to provide easily accessible, free health services to the populace of Bradford to help improve the standard of living, but also to help their medical students gain real life exposure to treating patients.

The scheme is part of DHEZ, a revolutionary new company which aims to tackle the struggles of public health via digital solutions.

PTS are extremely proud to be playing our part in this scheme. We will be providing phlebotomy training courses every couple of weeks to classes of no more than 10 people. Being a revolutionary new approach to health it will require a lot of research to develop and implement properly. This means taking blood.

Not only this, but the ease of which the public of Bradford can access the course means that we will be helping more people than ever find work in the health sector by working as phlebotomists.

To find out more about DHEZ you can visit their site here. Or to find out more about the basic course which we will be providing there you can visit this page.


PTS Help Dales Divas Raise over £13,000 for Charity

The work that we do at phlebotomy Training Services is intrinsically linked with the healthcare sector. We estimate that the overwhelming majority of our students either currently work in the healthcare sector or have plans to once they are fully qualified phlebotomists.

We are also huge advocates of charity. Our staff regularly undertake sponsored races and events in order to push themselves while raising money for charities. That being said, we are not averse to letting our hair down occasionally. And on that note the PTS team recently had a wonderful time attending a charity ball organised by the Dales Divas that was raising funds for breast cancer research.

Most of the team attended the masked ball, and looked amazing in their gowns and suits. Andrew had fun in particular as he acted as the auctioneer for the night.

There were many sore heads the next morning, but the knowledge that over £13,000 was raised helped us battle through the next few days and get us back to the office.

We are delighted to have played our part in the night, and hope that, just like we do with our students, our efforts go some way toward making the world a slightly better place.

To find out more about our courses, or the career paths a phlebotomist might take in the healthcare sector, simply click here or call us on 01609 751 610.


What If Your Blood Could Kill Mosquitoes?

A commonly used anti-parasite drug could be the next weapon in the fight against malaria. Researchers from Kenya and the United Kingdom have reported that dosing people with ivermectin, a drug commonly used in heartworm pills, makes them deadly targets for the mosquitoes that transmit malaria. Their studies showed that nearly all the mosquitoes in the experiment died after drinking the ivermectin-laced blood.

Malaria rates have dropped dramatically over the years, although, the disease still afflicts over 200 million people a year and was responsible for nearly half a million deaths in 2015. There are worries that resistance to artemisinin, the drug typically used for combating malaria, could continue to spread beyond Southeast Asia, where most resistant strains are currently found.

Ivermectin could be another solution. Researchers gave 47 malaria patients 600mg doses of ivermectin for three consecutive days, around three-times the regular dosage. After feeding the patients’ blood to mosquitoes, the researchers reported that 97% of the insects died after two weeks, and the blood remained deadly for up to 28 days.

Patients, meanwhile, reported to experience little side effects. A separate group of patients received doses of 300mg per day, but the mosquito-killing effect wasn’t as strong.

It remains unknown how safe the drug is for children, especially at such high doses. Researchers also noted that their participants were all malaria patients, so the effects could differ in healthy people. There are also worries of drug resistance of ivermectin as well, if it begins to see widespread use, mosquitoes may begin to evolve immunity.

The drug represents a cheap and easily obtainable method of mosquito control that could help control the spread of one of the world’s most deadly diseases. However, more in depth drug research is required before this can become an effective treatment.

If you’re interested in the study and research of blood, perhaps you’d like to acquire Phlebotomy skills? Our short, in-depth courses are a great way to kick-start your career in medicine. Book your place today or call us on 01609 751 610 for more information.